Decreased platelet reactivity in blood anticoagulated with bivalirudin or enoxaparin compared with unfractionated heparin: implications for coronary intervention.
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 13 (3) , 161-165
- https://doi.org/10.1023/a:1020478923794
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: A potential contributor to cardiovascular riskAmerican Journal of Kidney Diseases, 2002
- Platelet Reactivity Characterized ProspectivelyCirculation, 2001
- Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudyThe American Journal of Cardiology, 2000
- Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin InhibitorCirculation, 1998
- Optimally functional fluorescein isothiocyanate‐labelled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregationBritish Journal of Haematology, 1996
- Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4.Circulation, 1994
- Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.Circulation, 1993
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- Inhibition of Thrombin Induced Aggregation of Human Platelets by HeparinScandinavian Journal of Haematology, 1971